| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000031119 |
| Receipt No. | R000035528 |
| Official scientific title of the study | clinical evaluation trial about prediction of treatment effect of chemotherapy or chemoradiotherapy for gastrointestinal cancer using oxygen saturation imaging endoscopy |
| Date of disclosure of the study information | 2018/02/02 |
| Last modified on | 2018/02/02 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | clinical evaluation trial about prediction of treatment effect of chemotherapy or chemoradiotherapy for gastrointestinal cancer using oxygen saturation imaging endoscopy | |
| Title of the study (Brief title) | clinical evaluation trial using OSI endoscopy | |
| Region |
|
|
| Condition | ||
| Condition | esophageal cancer, gastric cancer, and colorectal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To evaluate the clinical efficacy of oxygen saturation imaging endoscopy about prediction of treatment efficacy of chemotherapy or chemoradiotherapy for gastrointestinal cancer. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | correlation between oxygen saturation of tissue surface before chemotherapy or chemoradiotherapy evaluated with oxygen saturation imaging and treatment efficacy |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | oxygen saturation imaging | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) >= 20 years old.
2) ECOG performance status of <= 2. 3) Written informed consent. 4) The following treatments are scheduled for esophageal, gastric, or colorectal advanced cancer. a. Neoadjuvant chemotherapy with DCF regimen and surgery scheduled for esophageal cancer. b. Definitive chemoradiotherapy scheduled for esophageal cancer. c. Initial chemotherapy scheduled for unresectable gastric cancer. d. Initial chemotherapy scheduled for unresectable colorectal cancer. |
|||
| Key exclusion criteria | 1) Psychosis.
2) Ileus, obstruction or perforation of the digestive tract has been diagnosed or is suspected. 3) Active bacterial or fungal infection. 4) History of myocardial infarction or unstable angina pectoris within three months. 5) Ineligible judged by attending doctor. |
|||
| Target sample size | 70 | |||
| Research contact person | |
| Name of lead principal investigator | Tomonori Yano |
| Organization | National Cancer Center Hospital East |
| Division name | Department of Gastroenterology and Endoscopy |
| Address | 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan |
| TEL | 04-7133-1111 |
| toyano@east.ncc.go.jp | |
| Public contact | |
| Name of contact person | Yusuke Yoda |
| Organization | National Cancer Center Hospital East |
| Division name | Department of Gastroenterology and Endoscopy |
| Address | 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan |
| TEL | 04-7133-1111 |
| Homepage URL | |
| yuyoda@east.ncc.go.jp | |
| Sponsor | |
| Institute | National Cancer Center Hospital East |
| Institute | |
| Department | |
| Funding Source | |
| Organization | National Cancer Center |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立がん研究センター東病院(千葉県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035528 |